224 related articles for article (PubMed ID: 19863913)
41. Metrological Traceability of Assays and Comparability of Patient Test Results.
Armbruster D
Clin Lab Med; 2017 Mar; 37(1):119-135. PubMed ID: 28153360
[TBL] [Abstract][Full Text] [Related]
42. Harmonization of immunoassays to the all-procedure trimmed mean - proof of concept by use of data from the insulin standardization project.
Van Houcke SK; Van Aelst S; Van Uytfanghe K; Thienpont LM
Clin Chem Lab Med; 2013 May; 51(5):e103-5. PubMed ID: 23152424
[No Abstract] [Full Text] [Related]
43. Growth hormone assays: current methodologies and their limitations.
Bidlingmaier M; Strasburger CJ
Pituitary; 2007; 10(2):115-9. PubMed ID: 17429592
[TBL] [Abstract][Full Text] [Related]
44. Unusual results from immunoassays and the role of the clinical endocrinologist.
Jones AM; Honour JW
Clin Endocrinol (Oxf); 2006 Mar; 64(3):234-44. PubMed ID: 16487430
[No Abstract] [Full Text] [Related]
45. Standardization of testosterone measurements in humans.
Vesper HW; Botelho JC
J Steroid Biochem Mol Biol; 2010 Aug; 121(3-5):513-9. PubMed ID: 20302935
[TBL] [Abstract][Full Text] [Related]
46. Signal amplification systems in immunoassays: implications for clinical diagnostics.
Dhawan S
Expert Rev Mol Diagn; 2006 Sep; 6(5):749-60. PubMed ID: 17009908
[TBL] [Abstract][Full Text] [Related]
47. Harmonization of immune biomarker assays for clinical studies.
van der Burg SH; Kalos M; Gouttefangeas C; Janetzki S; Ottensmeier C; Welters MJ; Romero P; Britten CM; Hoos A
Sci Transl Med; 2011 Nov; 3(108):108ps44. PubMed ID: 22072636
[TBL] [Abstract][Full Text] [Related]
48. Insulin immunoassays: fast approaching 50 years of existence and still calling for standardization.
Sapin R
Clin Chem; 2007 May; 53(5):810-2. PubMed ID: 17468407
[No Abstract] [Full Text] [Related]
49. Defining permissible limits for the combined uncertainty budget in the implementation of metrological traceability.
Braga F; Panteghini M
Clin Biochem; 2018 Jul; 57():7-11. PubMed ID: 29526674
[TBL] [Abstract][Full Text] [Related]
50. Standardization and calibration of cytokine immunoassays: meeting report and recommendations.
Wadhwa M; Thorpe R
Cytokine; 1997 Nov; 9(11):791-3. PubMed ID: 9367538
[No Abstract] [Full Text] [Related]
51. [Problems with carrying out the communalization of reference intervals: from the results of a questionnaire survey sent out by the Society of the Hitachi Automatic Clinical Analyzer].
Nakajima Y; Yamamoto Y; Matuo S
Rinsho Byori; 2009 Sep; 57(9):842-7. PubMed ID: 19860209
[TBL] [Abstract][Full Text] [Related]
52. Immunoassay techniques.
Wheeler MJ
Methods Mol Biol; 2013; 1065():7-25. PubMed ID: 23996355
[TBL] [Abstract][Full Text] [Related]
53. Standardization of Lp(a) measurements.
Kostner GM; Steinmetz A
Clin Genet; 1997 Nov; 52(5):393-7. PubMed ID: 9520132
[TBL] [Abstract][Full Text] [Related]
54. Growth hormone immunoassays: proposal to reduce interlaboratory variability.
Anckaert E; Schiettecatte J; Smitz J; Vanbesien J; De Schepper J
Clin Chem Lab Med; 2002 Oct; 40(10):1063-5. PubMed ID: 12476951
[No Abstract] [Full Text] [Related]
55. Toward standardization of insulin immunoassays.
Miller WG; Thienpont LM; Van Uytfanghe K; Clark PM; Lindstedt P; Nilsson G; Steffes MW;
Clin Chem; 2009 May; 55(5):1011-8. PubMed ID: 19325009
[TBL] [Abstract][Full Text] [Related]
56. Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable results.
Vitzthum F; Siest G; Bunk DM; Preckel T; Wenz C; Hoerth P; Schulz-Knappe P; Tammen H; Adamkiewicz J; Merlini G; Anderson NL
Proteomics Clin Appl; 2007 Sep; 1(9):1016-35. PubMed ID: 21136754
[TBL] [Abstract][Full Text] [Related]
57. Commercial immunoassays for human relaxin-2.
Stewart DR
Mol Cell Endocrinol; 2019 May; 487():94-97. PubMed ID: 30633956
[TBL] [Abstract][Full Text] [Related]
58. Overcoming challenges regarding reference materials and regulations that influence global standardization of medical laboratory testing results.
Miller WG; Myers G; Cobbaert CM; Young IS; Theodorsson E; Wielgosz RI; Westwood S; Maniguet S; Gillery P
Clin Chem Lab Med; 2023 Jan; 61(1):48-54. PubMed ID: 36239374
[TBL] [Abstract][Full Text] [Related]
59. A framework for T cell assays.
Britten CM; van der Burg SH; Gouttefangeas C
Oncotarget; 2015 Nov; 6(34):35143-4. PubMed ID: 26506424
[No Abstract] [Full Text] [Related]
60. The value of immunoassays for metanephrines in the biochemical diagnosis of pheochromocytomas.
Unger N; Deutschbein T; Walz MK; Mann K; Petersenn S
Horm Metab Res; 2009 Sep; 41(9):676-9. PubMed ID: 19557670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
